XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Schedule of Impact to Financial Statements Upon Adoption of ASC 326

The following table illustrates the impact to our financial statements as of January 1, 2022 upon adoption of ASC 326:

 

 

January 1, 2022

 

(In thousands)

Impact to Consolidated Statement of Condition from ASC-326 Adoption

 

 

Tax Effect

 

 

Impact to Retained Earnings from ASC-326 Adoption

 

Allowance for credit losses on loans

$

5,536

 

 

$

(1,490

)

 

$

4,046

 

Allowance for credit losses on off-balance sheet commitments

 

(188

)

 

 

51

 

 

 

(137

)

Total impact from ASC 326 adoption

$

5,348

 

 

$

(1,439

)

 

$

3,909

 

Schedule of Changes in Options Outstanding hanges in options outstanding during the nine months ended September 30, 2023 were as follows:

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

 

Weighted

 

 

Average

 

Aggregate

 

 

 

 

 

 

Average

 

 

Remaining

 

Intrinsic

 

 

 

Number of

 

 

Exercise

 

 

Contractual

 

Value

 

 

 

Options

 

 

Price

 

 

Term

 

(In thousands)

 

Balance, January 1, 2023

 

 

6,800

 

 

$

16.53

 

 

 

 

 

 

Exercised during 2023

 

 

(1,400

)

 

 

15.03

 

 

 

 

 

 

Expired during 2023

 

 

(2,600

)

 

 

14.85

 

 

 

 

 

 

Forfeited during 2023

 

 

(200

)

 

 

17.14

 

 

 

 

 

 

Balance, September 30, 2023

 

 

2,600

 

 

$

18.98

 

 

0.32 years

 

$

17

 

Vested and expected to vest

 

 

2,600

 

 

$

18.98

 

 

0.32 years

 

$

17

 

Exercisable at September 30, 2023

 

 

2,600

 

 

$

18.98

 

 

0.32 years

 

$

17

 

Schedule of Changes in Non-Vested Performance-Based Shares

Changes in non-vested shares dependent on performance criteria for the nine months ended September 30, 2023 were as follows:

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Balance, January 1, 2023

 

 

233,556

 

 

$

23.77

 

Granted during 2023

 

 

126,821

 

 

 

26.81

 

Vested during 2023

 

 

(177,072

)

 

 

16.93

 

Forfeited during 2023

 

 

(247

)

 

 

13.44

 

Balance, September 30, 2023

 

 

183,058

 

 

$

32.50

 

Schedule of Changes in Service-Based Restricted Stock Awards/Units

Changes in service-based restricted stock awards/units for the nine months ended September 30, 2023 were as follows:

 

 

 

 

 

Weighted

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

 

 

Shares

 

 

Fair Value

 

Balance, January 1, 2023

 

 

621,170

 

 

$

27.50

 

Granted during 2023

 

 

271,387

 

 

 

30.94

 

Vested during 2023

 

 

(252,837

)

 

 

26.07

 

Forfeited during 2023

 

 

(6,778

)

 

 

29.27

 

Balance, September 30, 2023

 

 

632,942

 

 

$

29.53

 

Schedule of Calculation of Basic and Diluted Earnings per Share The following is a reconciliation of the calculation of basic and diluted earnings per share. Basic net income per share is calculated by dividing net income available to shareholders by the weighted average shares outstanding during the reporting period. Diluted net income per share is computed similarly to that of basic net income per share, except that the denominator is increased to include the number of additional shares that would have been outstanding utilizing the Treasury Stock Method if all shares underlying potentially dilutive stock options were issued and all shares of restricted stock, stock warrants or restricted stock units were to vest during the reporting period.

 

Three Months Ended

 

 

Nine Months Ended

 

 

September 30,

 

 

September 30,

 

(Dollars in thousands, except per share data)

2023

 

 

2022

 

 

2023

 

 

2022

 

Net income available to common shareholders

$

8,755

 

 

$

20,126

 

 

$

40,255

 

 

$

53,667

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic weighted average shares outstanding

 

17,856,961

 

 

 

18,072,385

 

 

 

17,876,316

 

 

 

18,244,691

 

Plus: common stock equivalents

 

153,166

 

 

 

348,276

 

 

 

215,208

 

 

 

407,351

 

Diluted weighted average shares outstanding

 

18,010,127

 

 

 

18,420,661

 

 

 

18,091,524

 

 

 

18,652,042

 

Net income per share

 

 

 

 

 

 

 

 

 

 

 

Basic

$

0.49

 

 

$

1.11

 

 

$

2.25

 

 

$

2.94

 

Diluted

 

0.49

 

 

 

1.09

 

 

 

2.23

 

 

 

2.88